These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31992618)

  • 1. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
    Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.
    Sonoiki E; Ng CL; Lee MC; Guo D; Zhang YK; Zhou Y; Alley MR; Ahyong V; Sanz LM; Lafuente-Monasterio MJ; Dong C; Schupp PG; Gut J; Legac J; Cooper RA; Gamo FJ; DeRisi J; Freund YR; Fidock DA; Rosenthal PJ
    Nat Commun; 2017 Mar; 8():14574. PubMed ID: 28262680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
    Kreutzfeld O; Tumwebaze PK; Okitwi M; Orena S; Byaruhanga O; Katairo T; Conrad MD; Rasmussen SA; Legac J; Aydemir O; Giesbrecht D; Forte B; Campbell P; Smith A; Kano H; Nsobya SL; Blasco B; Duffey M; Bailey JA; Cooper RA; Rosenthal PJ
    Microbiol Spectr; 2023 Jun; 11(3):e0523622. PubMed ID: 37158739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esterase mutation is a mechanism of resistance to antimalarial compounds.
    Istvan ES; Mallari JP; Corey VC; Dharia NV; Marshall GR; Winzeler EA; Goldberg DE
    Nat Commun; 2017 Jan; 8():14240. PubMed ID: 28106035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.
    Sonoiki E; Palencia A; Guo D; Ahyong V; Dong C; Li X; Hernandez VS; Zhang YK; Choi W; Gut J; Legac J; Cooper R; Alley MR; Freund YR; DeRisi J; Cusack S; Rosenthal PJ
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4886-95. PubMed ID: 27270277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Some But Not Other Dimeric Lindenane Sesquiterpenoid Esters Is Mediated by Mutations in a
    Butler JH; Baptista RP; Valenciano AL; Zhou B; Kissinger JC; Tumwebaze PK; Rosenthal PJ; Cooper RA; Yue JM; Cassera MB
    ACS Infect Dis; 2020 Nov; 6(11):2994-3003. PubMed ID: 32970404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes.
    Magistrado PA; Corey VC; Lukens AK; LaMonte G; Sasaki E; Meister S; Wree M; Winzeler E; Wirth DF
    ACS Infect Dis; 2016 Nov; 2(11):816-826. PubMed ID: 27933786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity.
    Edgar RCS; Malcolm TR; Siddiqui G; Giannangelo C; Counihan NA; Challis M; Duffy S; Chowdhury M; Marfurt J; Dans M; Wirjanata G; Noviyanti R; Daware K; Suraweera CD; Price RN; Wittlin S; Avery VM; Drinkwater N; Charman SA; Creek DJ; de Koning-Ward TF; Scammells PJ; McGowan S
    mBio; 2024 Jun; 15(6):e0096624. PubMed ID: 38717141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro resistance selections for Plasmodium falciparum dihydroorotate dehydrogenase inhibitors give mutants with multiple point mutations in the drug-binding site and altered growth.
    Ross LS; Gamo FJ; Lafuente-Monasterio MJ; Singh OM; Rowland P; Wiegand RC; Wirth DF
    J Biol Chem; 2014 Jun; 289(26):17980-95. PubMed ID: 24782313
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kreutzfeld O; Orena S; Okitwi M; Tumwebaze PK; Byaruhanga O; Katairo T; Conrad MD; Legac J; Garg S; Crudale R; Aydemir O; Giesbrecht D; Nsobya SL; Blasco B; Duffey M; Rouillier M; Bailey JA; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0046624. PubMed ID: 39136468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium berghei K13 Mutations Mediate
    Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal surveillance of drug resistance in Plasmodium falciparum isolates from the China-Myanmar border reveals persistent circulation of multidrug resistant parasites.
    Bai Y; Zhang J; Geng J; Xu S; Deng S; Zeng W; Wang Z; Ngassa Mbenda HG; Zhang J; Li N; Wu Y; Li C; Liu H; Ruan Y; Cao Y; Yang Z; Cui L
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):320-328. PubMed ID: 29793059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.
    Nsobya SL; Kiggundu M; Nanyunja S; Joloba M; Greenhouse B; Rosenthal PJ
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1200-6. PubMed ID: 20065051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of
    Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N
    Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in
    Schalkwijk J; Allman EL; Jansen PAM; de Vries LE; Verhoef JMJ; Jackowski S; Botman PNM; Beuckens-Schortinghuis CA; Koolen KMJ; Bolscher JM; Vos MW; Miller K; Reeves SA; Pett H; Trevitt G; Wittlin S; Scheurer C; Sax S; Fischli C; Angulo-Barturen I; Jiménez-Diaz MB; Josling G; Kooij TWA; Bonnert R; Campo B; Blaauw RH; Rutjes FPJT; Sauerwein RW; Llinás M; Hermkens PHH; Dechering KJ
    Sci Transl Med; 2019 Sep; 11(510):. PubMed ID: 31534021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia.
    Dwivedi A; Reynes C; Kuehn A; Roche DB; Khim N; Hebrard M; Milanesi S; Rivals E; Frutos R; Menard D; Mamoun CB; Colinge J; Cornillot E
    Malar J; 2017 Dec; 16(1):493. PubMed ID: 29258508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of drug resistance genes in Indian Plasmodium falciparum and Plasmodium vivax field isolates.
    Narang G; Jakhan J; Tamang S; Yadav K; Singh V
    Acta Trop; 2024 Jul; 255():107218. PubMed ID: 38636585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.